How Do You Spell ALPHA DIFLUOROMETHYLORNITHINE?

Pronunciation: [ˈalfə dˈɪflʊ͡əɹˌə͡ʊmθɪlˌɔːnɪθˌa͡ɪn] (IPA)

The word "alpha Difluoromethylornithine" is a mouthful, but its spelling reflects its chemical composition. The first part, "alpha", is pronounced as "ælfə" in IPA, while "Difluoromethyl" is pronounced as "daɪˌfluəroʊˈmɛθəl". "Ornithine" is pronounced "ɔːrˈnɪθiːn". When combined, the pronunciation sounds like "alfə daɪˌfluəroʊˈmɛθəlˈɔːrˈnɪθiːn". This tongue-twister of a word is a medical drug used to treat cancer and parasites. Its spelling may seem intimidating, but it accurately reflects its composition and pronunciation.

ALPHA DIFLUOROMETHYLORNITHINE Meaning and Definition

1. Alpha Difluoromethylornithine (DFMO) is a synthetic compound that functions as an irreversible inhibitor of the enzyme ornithine decarboxylase (ODC). It is derived from the amino acid ornithine and is primarily used as a pharmaceutical agent in cancer research and treatment.

   ODC plays a crucial role in polyamine biosynthesis, a process involved in cell growth, proliferation, and differentiation. Polyamines are organic compounds that regulate various cellular functions and are particularly essential for rapid cell division. As DFMO inhibits ODC, it prevents the conversion of ornithine into putrescine, ultimately decreasing the levels of polyamines within cells.

   Due to its mechanism of action, DFMO has been investigated as a therapeutic option for various cancers, including colorectal cancer, neuroblastoma, and certain types of skin cancer. By depleting polyamines, DFMO aims to impede cancer cell growth and division, potentially slowing down tumor progression. Additionally, DFMO may exhibit chemopreventive properties, reducing the risk of cancer development.

   DFMO is typically administered orally or topically, depending on the condition being treated. While generally well-tolerated, it may cause side effects such as gastrointestinal disturbances, fatigue, and ototoxicity in rare cases.

   In summary, alpha Difluoromethylornithine (DFMO) is a pharmaceutical compound that inhibits ornithine decarboxylase, an enzyme involved in polyamine biosynthesis. Its primary use is in cancer research and treatment, with the aim of reducing tumor growth and potentially preventing cancer development.

Common Misspellings for ALPHA DIFLUOROMETHYLORNITHINE

• zlpha difluoromethylornithine
• slpha difluoromethylornithine
• wlpha difluoromethylornithine
• qlpha difluoromethylornithine
• akpha difluoromethylornithine
• appha difluoromethylornithine
• aopha difluoromethylornithine
• aloha difluoromethylornithine
• allha difluoromethylornithine
• al-ha difluoromethylornithine
• al0ha difluoromethylornithine
• alpga difluoromethylornithine
• alpba difluoromethylornithine
• alpna difluoromethylornithine
• alpja difluoromethylornithine
• alpua difluoromethylornithine
• alpya difluoromethylornithine
• alphz difluoromethylornithine
• alphs difluoromethylornithine
• alphw difluoromethylornithine

Etymology of ALPHA DIFLUOROMETHYLORNITHINE

The word "alpha Difluoromethylornithine" has a scientific and systematic naming convention, which is not based on etymology or historical origins like most common words. It is a complex chemical name that describes the structure and composition of a compound.

"Alpha" refers to the position of a functional group or substituent on a molecule, indicating that the "Difluoromethylornithine" compound has the substituent attached to its alpha carbon atom.

"Difluoromethyl" indicates the presence of two fluorine atoms attached to a methyl group, which is a carbon atom bonded to three hydrogen atoms.

"Ornithine" is a naturally occurring amino acid involved in protein synthesis and other biological processes.

So, the name "alpha Difluoromethylornithine" describes a compound with a difluoromethyl substituent attached to the alpha carbon of an ornithine molecule.